诺瓦瓦克斯医药 | 7.52 -0.32 -4.08% | ||
| NVAX | |||
| 高 7.88 | 开 7.85 | 量 810.41万股 | 总市值 12.21亿 |
| 低 7.43 | 换 4.99% | 额 6122.75万 | 市盈TTM 2.89 |
分时
5日
日K
周K
月K
季K
年K
诺瓦瓦克斯医药(NVAX)
08-21 19:55
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001104659-25-081160 Act: 34 Size: 379 KB 网页链接
诺瓦瓦克斯医药(NVAX)
08-06 20:05
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001000694-25-000031 Act: 34 Size: 311 KB 网页链接
诺瓦瓦克斯医药(NVAX)
08-06 19:55
$诺瓦瓦克斯医药(NVAX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001000694-25-000029 Act: 34 Size: 10 MB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062192 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062191 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062193 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062195 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062196 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-25 06:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-062194 Size: 8 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-24 18:05
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, item 5.07 Accession Number: 0001104659-25-061874 Act: 34 Size: 194 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-17 04:15
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-25-000783 Size: 6 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-17 04:15
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-25-000784 Size: 6 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-14 09:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-25-000758 Size: 6 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-14 09:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-25-000760 Size: 6 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-14 09:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-25-000757 Size: 6 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-14 09:45
$诺瓦瓦克斯医药(NVAX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-25-000759 Size: 6 KB 网页链接
诺瓦瓦克斯医药(NVAX)
06-11 19:05
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-25-058379 Act: 34 Size: 16 MB 网页链接
诺瓦瓦克斯医药(NVAX)
05-28 04:15
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, item 5.02 Accession Number: 0001104659-25-052959 Act: 34 Size: 191 KB 网页链接
诺瓦瓦克斯医药(NVAX)
05-20 04:45
$诺瓦瓦克斯医药(NVAX)$ 144 Report of proposed sale of securities Accession Number: 0002007317-25-000417 Act: 33 Size: 5 KB 网页链接
诺瓦瓦克斯医药(NVAX)
05-19 19:45
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 7.01 and 8.01 Accession Number: 0001104659-25-050226 Act: 34 Size: 198 KB 网页链接